Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

La Rabta Hospital, Tunis

University Hospital of Lausanne, Lausanne

Hedi Chaker Hospital, Department of Dermatology, Tunisia

Farhat Hached Hospital, Sousse

National Taiwan University Hospital, Taipei

Icahn School of Medicine at Mount Sinai, New York

Charité - Universitätsmedizin Berlin, Berlin

Ramathibodi Hospital, Ratchatewi, Bangkok

Hospital Pulau Pinang, Pulau Pinang

Tianjin Medical University General Hospital, Tianjin

Hospital Raja Permaisuri Bainun, Negeri Perak/Ipoh

HOP Saint-André, Bordeaux

University of Miami, Miami

University of South Florida, Tampa

University of Alabama at Birmingham, Birmingham

Universitätsklinikum Essen AöR, Essen

Hospital Kuala Lumpur, Kuala Lumpur

HOP Robert Debré, Reims

Universitätsklinikum Bonn AöR, Bonn

Hospital Selayang, Kuala Selangor

HOP Saint-Louis, Paris

Hospital Sultanah Aminah, Johor Bahru

Klinikum der Universität München - Campus Innenstadt, München

Hospital Sultan Ismail, Johor Bahru

Hospital Pakar Sultanah Fatimah, Muar town

The First Hospital of Dalian Medical University, Dalian

National University Hospital, Singapore

Shanghai Skin Disease Hospital, Shanghai

Huashan Hospital, Fudan University, Shanghai

2nd Affiliated Hosp Zhejiang University College of Medical, Hangzhou

Nagoya City University Hospital, Aichi, Nagoya

Fukuoka University Hospital, Fukuoka, Fukuoka

Asahikawa Medical University Hospital, Hokkaido, Asahikawa

Tohoku University Hospital, Miyagi, Sendai

Tokyo Medical University Hachioji Medical Center, Tokyo, Hachioji

Tokyo Medical University Hospital, Tokyo, Shinjuku-ku

Severance Hospital, Seoul